No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CTXR Citius Pharmaceuticals
- 2.6000
- +0.0300+1.17%
Close Dec 20 16:00 ET
- 2.5700
- -0.0300-1.15%
Post 20:01 ET
20.09MMarket Cap-0.43P/E (TTM)
2.7400High2.4800Low100.12KVolume2.5100Open2.5700Pre Close260.84KTurnover1.31%Turnover RatioLossP/E (Static)7.73MShares26.750052wk High0.23P/B19.84MFloat Cap2.440052wk Low--Dividend TTM7.63MShs Float750.0000Historical High--Div YieldTTM10.12%Amplitude2.4400Historical Low2.6050Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Citius Pharmaceuticals Inc - Regains Compliance With Nasdaq Listing Rule 5550(a)(2)
Maxim Group Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven?
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval
Heat List
US
Overall
Symbol
Price
% Chg
No Data